Cell Therapy

MD Anderson Launches Institute for Pioneering Cell Therapy Research
Research & Development MD Anderson Launches Institute for Pioneering Cell Therapy Research

The University of Texas MD Anderson Cancer Center has unveiled its ambitious new initiative, the Institute for Cell Therapy Discovery & Innovation, fueled by an impressive initial funding of over $80 million. This pioneering institute aims to revolutionize the realms of immunology and cell

November 12, 2024
FDA Approves Aucatzyl, a New CAR-T Therapy to Rival Tecartus
Research & Development FDA Approves Aucatzyl, a New CAR-T Therapy to Rival Tecartus

The recent approval of Aucatzyl by the FDA marks a significant advancement in the treatment landscape for patients with B-cell precursor acute lymphoblastic leukemia, especially those whose disease has progressed following initial chemotherapy treatments. Developed by U.K.-based Autolus

November 12, 2024
How Will Trump's Leadership Change FDA and Biotech Regulation?
Research & Development How Will Trump's Leadership Change FDA and Biotech Regulation?

The victory of Donald Trump in the U.S. presidential election has sparked widespread speculation about the potential changes within federal health agencies, particularly the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC). Trump's past and potential future choices for

November 8, 2024
What Are the Top 10 Biopharma Hubs in the U.S. for 2024?
Management & Regulatory What Are the Top 10 Biopharma Hubs in the U.S. for 2024?

The biopharma industry in the United States continues to thrive, driven by innovation, substantial funding, and strategic collaborations. As we look ahead to 2024, certain regions stand out as leading hubs for biopharma activity. The evolution of these hubs is fueled by various factors, including

November 8, 2024
What Is Driving Sana Biotechnology's Major Strategic Shift?
Research & Development What Is Driving Sana Biotechnology's Major Strategic Shift?

In a significant move just three years post its highly successful IPO, Sana Biotechnology has announced a strategic restructuring that will likely reshape the company's future and impact. This overhaul will include layoffs and a refocused research directive, marking a notable shift in

November 7, 2024
Revolutionizing Biomanufacturing: Real-Time Analytics with Laser Force Cytology
Management & Regulatory Revolutionizing Biomanufacturing: Real-Time Analytics with Laser Force Cytology

In today's rapidly evolving field of biomanufacturing, traditional methods often fall short of the rigorous demands for real-time data and consistent product quality. Laser Force Cytology (LFC) has emerged as an innovative, label-free technology that offers a transformative approach to

November 7, 2024
Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for subscribing.
We'll be sending you our best soon.
Something went wrong, please try again later